ARCHIVES

ORI Says COMS Study Coordinator Committed Scientific Misconduct

This article is from The Cancer Letter archive.

Vol. 22 No. 15 | April 12, 1996

Download PDF Visit The Full Archive

Related Articles

“I’m Not Bummed Out By This” – Broder

December 22, 1994

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990